OWP PHARMACEUTICALS, INC. — Form D
OWP PHARMACEUTICALS, INC. of LISLE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-09. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-09-09
- Form: D
- Accession: 0002037010-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $2.4M
- Minimum investment: $25K
- Investors: 19
- Date of first sale: 2025-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-557097
Issuer
- Name: OWP PHARMACEUTICALS, INC.
- CIK: 0002037010
- Entity type: Corporation
- Jurisdiction: ILLINOIS
- Address: 701 WARRENVILLE ROAD, LISLE, IL, 60532
- Phone: 847-722-0803
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Scott Boyer | Director | Prosper, TX |
| BRUCE DUNCAN | Director | LISLE, IL |
| KURT FLORIAN | Director | LISLE, IL |
| TROY HAMMOND | Director | LISLE, IL |
| MATT LITFIN | Director | LISLE, IL |
| STEVE BOURNE | Executive Officer | LISLE, IL |
| Scott Boyer | Executive Officer | Prosper, TX |
| CAROL GAVIN | Director | NAPERVILLE, IL |
| PAUL REGAN | Director | NAPERVILLE, IL |
Other filings by this issuer (1)
More